AAAAAA

   
Results: 1-10 |
Results: 10
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and areresistant to apoptosis induction
Authors: Riffkin, CD Gray, AZ Hawkins, CJ Chow, CW Ashley, DM
Citation: Cd. Riffkin et al., Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and areresistant to apoptosis induction, NEURO-ONCOL, 3(4), 2001, pp. 229-240
Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: Three case studies and a review of the literature
Authors: Hassall, TEG Mitchell, AE Ashley, DM
Citation: Teg. Hassall et al., Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: Three case studies and a review of the literature, NEURO-ONCOL, 3(4), 2001, pp. 251-257
Analysis of candidate antagonists of IAP-mediated caspase inhibition usingyeast reconstituted with the mammalian Apaf-1-activated apoptosis mechanism
Authors: Hawkins, CJ Silke, J Verhagen, AM Foster, R Ekert, PG Ashley, DM
Citation: Cj. Hawkins et al., Analysis of candidate antagonists of IAP-mediated caspase inhibition usingyeast reconstituted with the mammalian Apaf-1-activated apoptosis mechanism, APOPTOSIS, 6(5), 2001, pp. 331-338
Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells
Authors: Knight, MJ Riffkin, CD Muscat, AM Ashley, DM Hawkins, CJ
Citation: Mj. Knight et al., Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells, ONCOGENE, 20(41), 2001, pp. 5789-5798
Counterpoint - 'Chemotherapy is useful in treatment of gliomas' - Discussant
Authors: Ashley, DM
Citation: Dm. Ashley, Counterpoint - 'Chemotherapy is useful in treatment of gliomas' - Discussant, J CL NEUROS, 7(5), 2000, pp. 467-468
Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
Authors: Friedman, HS Pluda, J Quinn, JA Ewesuedo, RB Long, L Friedman, AH Cokgor, I Colvin, OM Haglund, MM Ashley, DM Rich, JN Sampson, J Pegg, AE Moschel, RC McLendon, RE Provenzale, JM Stewart, ES Tourt-Uhlig, S Garcia-Turner, AM Herndon, JE Bigner, DD Dolan, ME
Citation: Hs. Friedman et al., Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma, J CL ONCOL, 18(20), 2000, pp. 3522-3528
Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme
Authors: Bottom, KS Ashley, DM Friedman, HS Longee, DC
Citation: Ks. Bottom et al., Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme, J NEURO-ONC, 46(2), 2000, pp. 151-156
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Authors: Sampson, JH Crotty, LE Lee, S Archer, GE Ashley, DM Wikstrandt, CJ Hale, LP Small, C Dranoff, G Friedman, AH Friedman, HS Bigner, DD
Citation: Jh. Sampson et al., Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors, P NAS US, 97(13), 2000, pp. 7503-7508
Expression of MAGE and GAGE in high-grade brain tumors: A potential targetfor specific immunotherapy and diagnostic markers
Authors: Scarcella, DL Chow, CW Gonzales, MF Economou, C Brasseur, F Ashley, DM
Citation: Dl. Scarcella et al., Expression of MAGE and GAGE in high-grade brain tumors: A potential targetfor specific immunotherapy and diagnostic markers, CLIN CANC R, 5(2), 1999, pp. 335-341
DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma
Authors: Friedman, HS McLendon, RE Kerby, T Dugan, M Bigner, SH Henry, AJ Ashley, DM Krischer, J Lovell, S Rasheed, K Marchev, F Seman, AJ Cokgor, I Rich, J Stewart, E Colvin, OM Provenzale, JM Bigner, DD Haglund, MM Friedman, AH Modrich, PL
Citation: Hs. Friedman et al., DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma, J CL ONCOL, 16(12), 1998, pp. 3851-3857
Risultati: 1-10 |